Recent advances in p53 research: an interdisciplinary perspective.
about
Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancerInfluence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated ProteinsIdentification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.Mutant p53 gain-of-function in cancer.Clinical outcomes and correlates of TP53 mutations and cancer.Two different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?Chromatin-regulating proteins as targets for cancer therapy.Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.Limiting the power of p53 through the ubiquitin proteasome pathway.Unveiling the methylation status of CpG dinucleotides in the substituted segment of the human p53 knock-in (Hupki) mouse genome.Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair.p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysisTP53 mutation hits energy metabolism and increases glycolysis in breast cancer.Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel.Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.Nanoparticle-mediated p53 gene therapy for tumor inhibition.TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukaemia cases using multiple polymerases.Duplex Detection of TP53 Arg72Pro and 16 bp Del/Ins Polymorphisms by a Simple Optimized PCR-RFLP Method.Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice.Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression.Early onset HER2-positive breast cancer is associated with germline TP53 mutations.Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.Relevant Networks involving the p53 Signalling Pathway in Renal Cell Carcinoma.Harnessing synthetic lethal interactions in anticancer drug discoveryA miR-34a-SIRT6 axis in the squamous cell differentiation networkInhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.Role of p53 codon 72 polymorphism in chromosomal aberrations and mitotic index in patients with chronic hepatitis B.Pathogenesis of lung cancer signalling pathways: roadmap for therapies.Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies.Crossing paths in Human Renal Cell Carcinoma (hRCC).The TP73 complex network: ready for clinical translation in cancer?Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection.
P2860
Q27002356-E77E62AA-B604-4BEB-A65D-57AC3246E367Q28552225-3A1C3855-BF10-4DFC-B833-D1EF5A73326CQ30939321-BA6DA2AA-1E6A-465E-9EDC-11F1C3C47D6CQ33687048-4C58E094-5741-4D71-B36C-191ED5B7003AQ33693838-0993210E-DCFC-4D35-828B-5D64A7618105Q33865112-B16D3A00-217D-45BB-9D99-0CA0C957950CQ33907067-A98D16DE-77F9-4223-A32E-BCD9C1F81354Q34101582-0BD8EFE7-38A5-4844-A37A-41CAFE57F11FQ34103978-38863D1F-CA36-4EB1-B081-542F159FB717Q34342940-02B5C819-7F26-48E5-A453-3E6F86C5FE9FQ34348311-8435C47D-EEEF-4036-86C4-CCD96DF28C95Q34365755-419E21C4-C198-4165-B401-B4FA50C61084Q34430158-6DD1211B-3ACA-4C6C-9831-5D7360260EEBQ34539146-67D61B37-AA30-406C-8DD5-024D63DB4D93Q34631589-DA09114C-08BE-4984-93DD-F79C0D8F9695Q34768428-4568F98D-1C47-46CC-97F5-6AF54258DEDEQ34887528-ED3DAA5A-2385-4D63-9633-74A86C4B0EAFQ34980673-33D9D5B3-E71D-4E53-AC20-B927D61E1632Q35029530-2E46D429-9FD4-46B5-A301-3E2AEFB87362Q35496577-B80C706A-F2CC-466D-93C4-47CCBD7D18E8Q35921207-1A9CEEFF-2512-4D05-8550-17D8E9799BA2Q35921904-D1115A7E-F369-4049-9A7E-79E17CAE1474Q35978724-C653FD8A-EBC6-4CCB-BCAB-87D7E5B394C1Q35985230-6D65ED61-72CC-4E5D-9CB5-73053796E6BCQ36105141-00D57A91-F0C3-4E7B-9865-8ABC14EBDCAEQ36359259-5CBBA5EE-D165-4F58-899C-F22CC735F45CQ36481648-05ECC86D-7E1E-4376-AA82-2844E36A3A34Q36640056-C2F689C5-4267-4776-B246-46D88B49E7D6Q36730586-D93421AE-3ADC-49AD-AC2E-2B9EA086203AQ36735719-EED7C544-8C24-438A-8075-4E4EDCF36E96Q36839571-3731472C-4CFC-4A20-963E-719C9B5EAFF1Q37101911-7C3A45E2-4EC4-4BF0-8796-F7F00B84177AQ37261795-4AEEE43C-8766-4528-9277-2E819CAD8E5CQ37370785-CD304FC7-2745-419C-8AE0-9A5269A511B3Q37389526-F6EDE80D-0178-449F-A0F3-FE2ADFEB0553Q37802195-5F8D08FC-9A2E-404B-9EF2-612F662841FCQ38064316-EAC5B86C-3E3E-453F-9F7D-2763C272BB40Q38126476-CB73A257-EC20-48B9-B604-F1E9AEAD4C27Q38539917-556FF845-F520-447A-9117-8265493AF969Q38659248-8F7D2579-F7F3-4E4E-A1AA-0F23A0925FAB
P2860
Recent advances in p53 research: an interdisciplinary perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances in p53 research: an interdisciplinary perspective.
@en
Recent advances in p53 research: an interdisciplinary perspective.
@nl
type
label
Recent advances in p53 research: an interdisciplinary perspective.
@en
Recent advances in p53 research: an interdisciplinary perspective.
@nl
prefLabel
Recent advances in p53 research: an interdisciplinary perspective.
@en
Recent advances in p53 research: an interdisciplinary perspective.
@nl
P2093
P2860
P356
P1433
P1476
Recent advances in p53 research: an interdisciplinary perspective
@en
P2093
A Petitjean
C C de Fromentel
M Mounawar
P2860
P2888
P356
10.1038/CGT.2008.69
P577
2008-09-19T00:00:00Z